Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

ClinicalTrials.gov ID: NCT04803305

Public ClinicalTrials.gov record NCT04803305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6-WEEK, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN STUDY TO ASSESS THE EFFECT OF REPEATED SUBCUTANEOUS ADMINISTRATION OF PF-06946860 ON APPETITE IN PARTICIPANTS WITH ADVANCED CANCER AND ANOREXIA, FOLLOWED BY AN 18-WEEK OPEN-LABEL TREATMENT PERIOD

Study identification

NCT ID
NCT04803305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Pfizer
Industry
Enrollment
18 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 10, 2021
Primary completion
Apr 13, 2022
Completion
Aug 8, 2022
Last update posted
Jan 11, 2024

2021 – 2022

United States locations

U.S. sites
32
U.S. states
8
U.S. cities
24
Facility City State ZIP Site status
CARTI Cancer Center Little Rock Arkansas 72205
Tower Hematology Oncology Medical Group (THO) Beverly Hills California 90211
Ventura County Hematology- Oncology Specialists Camarillo California 93010
Cedars- Sinai Medical Center Los Angeles California 90048
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048
Cedars-Sinai Medical Center Los Angeles California 90048
Ventura County Hematology Oncology Specialists Oxnard California 93030
Providence Medical Foundation Santa Rosa California 95403
Ventura County Hematology-Oncology Specialists Ventura California 93003
Lutheran Medical Center Wheat Ridge Colorado 80033
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46804
Bozeman Health Cancer Center Bozeman Montana 59715
Bozeman Health Deaconess Hospital d/b/a Bozeman Health Clinical Research Bozeman Montana 59715
Bozeman Health Deaconess Hospital Bozeman Montana 59715
Mary Crowley Cancer Research Dallas Texas 75230
The University of Texas MD Anderson Cancer Center Houston Texas 77030
US Oncology Investigational Product Center (IPC) Irving Texas 75063
Texas Oncology - Longview Cancer Center Longview Texas 75601
Texas Oncology-Paris Paris Texas 75460
Texas Oncology- Tyler Tyler Texas 75702
Cancer Center IDS Pharmacy Charlottesville Virginia 22903
University of Virginia Cancer Center Charlottesville Virginia 22903
UVA Health System; Attention: GI Team Charlottesville Virginia 22903
University of Virginia Health System Charlottesville Virginia 22908
MultiCare Regional Cancer Center - Auburn Auburn Washington 98001
MultiCare Regional Cancer Center - Gig Harbor Medical Park Gig Harbor Washington 98335
Moses Lake Clinic Moses Lake Washington 98837
MultiCare Regional Cancer Center - Puyallup Puyallup Washington 98372
Medical Oncology Associates, PS (dba Summit Cancer Centers) Spokane Valley Washington 99216
MultiCare Institute for Research & Innovation Tacoma Washington 98405
MultiCare Regional Cancer Center - Tacoma Tacoma Washington 98405
Wenatchee Valley Hospital Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04803305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04803305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →